Codexis
(NASDAQ) CDXS
Codexis Financials at a Glance
Market Cap
$241.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$78.09M
Net Income (TTM)
-$31.99M
EPS (TTM)
-$0.36
P/E Ratio
-7.33
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Price
$2.60
Volume
773,272
Open
$2.62
Price
$2.60
Volume
773,272
Open
$2.62
Previous Close
$2.60
Daily Range
$2.46 - $2.66
52-Week Range
$0.96 - $3.87
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.95 (High)
Price
$2.60
Volume
773,272
Open
$2.62
Previous Close
$2.60
Daily Range
$2.46 - $2.66
52-Week Range
$0.96 - $3.87
Estimated Earnings Date
Aug 12, 2026
CDXS News
CDXS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Codexis
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
146
CEO
Alison Moore, PhD
Website
www.codexis.comHeadquarters
Redwood City, CA 94063, US
CDXS Financials
Key Financial Metrics (TTM)
Gross Margin
83.94%
Operating Margin
-33.15%
Net Income Margin
-40.96%
Return on Equity
-68.09%
Return on Capital
-30.98%
Return on Assets
-24.73%
Earnings Yield
-13.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$241.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
90.90M
Volume
773.27K
Avg. Volume
1.13M
Financials (TTM)
Gross Profit
$65.55M
Operating Income
-$25.89M
EBITDA
-$22.06M
Operating Cash Flow
-$18.73M
Capital Expenditure
-$3.39M
Free Cash Flow
-$22.12M
Cash & ST Invst.
$65.57M
Total Debt
$72.90M
Codexis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.25M
+102.1%
Gross Profit
$11.94M
+148.1%
Gross Margin
78.28%
N/A
Market Cap
$241.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.66M
N/A
Employees
146
N/A
Net Income
-$8.70M
+57.9%
EBITDA
-$6.45M
+63.8%
Quarterly Fundamentals
Total Cash
$65.57M
+9.7%
Total Debt
$72.90M
+22.5%
Accounts Receivable
$8.03M
-30.7%
Inventory
$2.00M
+12.3%
Long Term Debt
$69.60M
+23.0%
Short Term Debt
$3.30M
+13.4%
Return on Assets
-24.73%
N/A
Return on Invested Capital
-22.61%
N/A
Free Cash Flow
-$13.33M
+11.5%
Operating Cash Flow
-$13.15M
+4.7%